The inaugural Institutional Capital & Cannabis Investment Conference will be held on March 28th and 29th in San Jose, California.
The conference, sponsored by IMN and MedMen, will address the needs of institutional and accredited investors, enabling them to learn how to evaluate investment returns in the fast growing and emerging U.S. legal cannabis industry.
Jeffrey Friedland will participate on the panel, “Private Capital Investment Opportunities in the Cannabis Sector: The Investor’s Perspective.”
The Institutional Capital & Cannabis Investment Conference is the only event of its kind focused on the legal cannabis business as an alternative asset class to achieve portfolio diversification.
The conference program will provide an in-depth look into the emerging cannabis industry and provide to attendees information on evaluating investment returns in the legal cannabis industry.
The Institutional Capital & Cannabis Investment Conference is being endorsed by the National Cannabis Association, the California Cannabis Association, and the Marijuana Policy Project.
For more information on the conference, or to register to attend, please visit www.imn.org/ic3
MedMen is a leading cannabis firm based in Los Angeles with operations across North America. The Firm operates in two areas; MedMen Management offers turnkey services to cannabis license holders, and MedMen Capital makes strategic investments in key markets across the U.S. and Canada. (Website: www.medmen.com)
IMN, founded in 1994, is a global organizer of institutional finance & investment conferences. In 2004 the business was acquired by Euromoney Institutional Investor PLC, a UK company listed on the London Stock Exchange. (Website: www.imn.org)
About Jeffrey Friedland
Jeffrey Friedland is an emerging market pioneer -- his firm, Friedland Global Capital, was one of the first American investment banks to establish a presence in China -- and is now on the front lines of the cannabis industry as an investor and business owner. He is an author, speaker and thought leader on emerging markets, the global economy and the cannabis industry.
In his book, Marijuana, the World's Most Misunderstood Plant, Mr. Friedland dives into the world of marijuana, discussing what we know and what we still hope to discover.
Mr. Friedland was an owner of two retail marijuana stores in Colorado which were located in the mountain resort towns of Breckenridge and Crested Butte, and a marijuana cultivation facility south of Steamboat Springs, which were featured in CNN's eight-part, reality series, High Profits.
He is also CEO of privately-held INTIVA Inc., which has operating businesses and investments in the cannabis industry in California, Colorado, Israel, and Canada.
Mr. Friedland is a founder and early-stage investor in Israel-based, Israel Plant Sciences Ltd. (IPS), a company that is participating in Israel’s innovative agriculture and medicinal plant sectors and other agricultural related technologies. The company has four subsidiaries in Israel, with a focus on cannabis.
He is a board member of Israel-based CannRX, a company focused on the development of cannabis-based pharmaceuticals in Israel.
Jeffrey Friedland is also the CEO of Friedland Capital, which was formed in 1982.
Mr. Friedland has been the chief executive officer and a director of a NASDAQ listed financial services company, a director and chairman of the audit committee of a New York Stock Exchange listed company, and chairman of a company listed on the EU-regulated market of the Frankfurt Stock Exchange.
Mr. Friedland has been featured or quoted in numerous publications including the Wall Street Journal, Reuters, the New York Times, Bloomberg Television, USA Today, Verslo Zinios (Lithuania), Vercernji (Croatia), International Business Times, the South China Morning Post, the Guam Daily Post, the Forward, the Jewish Week, Quartz, the Jakarta Globe, Israel Daily Television, BreitBart, NBC.com and Forbes.
Jeffrey Friedland is a regular contributor to CannaInvestor Magazine.
(Jeffrey Friedland’s website: www.jeffreyfriedland.com)